Capital DailyCapital Daily
Markets · Investing · Business
Capital DailyCapital Daily
Finance

UnitedHealth Is Trouncing the Market in 2026. Is the Stock Still a Buy?

This recovery story is turning into a success story.

UnitedHealth Is Trouncing the Market in 2026. Is the Stock Still a Buy?

Published September 4, 2026 · Category: Finance

Overview

Last year, UnitedHealth Group's (NYSE: UNH) struggles with rising medical costs weighed significantly on earnings -- and on stock performance. But the company has since put into place a plan to turn things around, and that plan has been bearing fruit. Though UnitedHealth's challenges haven't disappeared, the company is better navigating the current market, and efforts are paving the way for long-term growth.

Earnings in the recent quarter, which surpassed estimates, confirmed this positive momentum. And investors haven't ignored this important turnaround story. They've piled into UnitedHealth shares, sending the stock to a 21% gain so far this year. Considering this market-beating performance, is the stock still a buy? Let's find out.

Image source: Getty Images.

Details

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.